Translation
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
October 31, 2025
Company name: NICCA CHEMICAL CO., ltd.
Stock exchange listings: Tokyo Stock Exchange
Stock code: 4463
URL: https://www.nicca.co.jp
Representative: Yasuaki Emori, President and Representative Director
Contact: Shoya Sawazaki, Director, Executive Officer, Head of Administration Division
TEL: +81 776-24-0213
Scheduled date for dividend payment:
Supplementary materials for financial summaries:
Yes
Financial results briefing: None
(Amounts of less than one million yen are rounded down.)
-
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2025 (from January 01, 2025 to September 30, 2025)
-
Consolidated operating results (Cumulative) (Percentage indicate YoY changes)
Revenue
Operating profit
Ordinary profit
Profit attributable to owners of parent
Nine months ended
Million yen
%
Million yen
%
Million yen
%
Million yen
%
September 30, 2025
41,217
4.4
2,901
15.7
2,759
(2.8)
1,613
(12.7)
September 30, 2024
39,476
5.4
2,508
88.6
2,839
56.3
1,848
81.6
(Note) Comprehensive income For the nine months ended December 31, 2025: 766 million yen ((66.0) %) For the nine months ended December 31, 2024: 2,253 million yen ((17.3) %)
Basic earnings per share
Diluted earnings per share
Nine months ended
Yen
Yen
September 30, 2025
101.76
-
September 30, 2024
116.89
-
-
Consolidated financial positions
Total assets
Equity
Equity to total assets ratio
Net assets per share
As of
Million yen
Million yen
%
Yen
September 30, 2025
66,489
36,411
50.2
2,098.47
December 31, 2024
62,366
36,553
54.0
2,125.60
(Reference) Owner's equity As of the third quarter of the fiscal year ending December 2025: 33,396 million yen As of the fiscal year ended December 2024: 33,650 million yen
-
Consolidated operating results (Cumulative) (Percentage indicate YoY changes)
-
Cash dividends
Annual dividends per share
End of first quarter
End of second quarter
End of the third quarter
Fiscal year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended
December 31, 2024
-
25.00
-
27.00
52.00
Fiscal year ending December 31, 2025
-
30.00
-
Fiscal year ending December 31, 2025 (Forecast)
30.00
60.00
(Note) Presence or absence of revisions from the most recently announced dividend forecast: None
- Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2025 (from January 01, 2025 to December 31,
(Percentages indicate YoY changes)
Revenue | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Fiscal year ending December 31, 2025 | Million yen | % | Million yen | % | Million yen | % | Million yen | % | Yen |
57,000 | 5.4 | 3,600 | 2.3 | 3,400 | (14.5) | 2,400 | (12.9) | 151.49 | |
(Note) Correction of financial forecast from the most recent financial forecast: None
Notes
Significant changes in the scope of consolidation during the period: None
Applying of specific accounting of the consolidated quarterly financial statements: Yes
Changes in accounting policies, changes in accounting estimates, retrospective restatement
Changes in accounting policies due to revisions of accounting standards : None
Changes in accounting policies other than (i): None
Changes in accounting estimates : None
Retrospective restatement : None
Number of shares issued (common stock)
Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2025
17,710,000 shares
As of December 31, 2024
17,710,000 shares
Number of treasury shares at the end of the period
As of September 30, 2025
1,795,367 shares
As of December 31, 2024
1,879,105 shares
Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Nine months ended September 30, 2025 | 15,852,078 shares |
Nine months ended September 30, 2024 | 15,813,750 shares |
※ Review of attached consolidated quarterly financial statements by a certified public accountant or an audit firm: None
Note: Explanation regarding the appropriate use of forecasts and other special notes (Cautionary Statement Regarding Forward-Looking Statements)
The forward-looking statements, including earnings forecasts, contained in this document are based on information currently available to the Company and on certain assumptions deemed reasonable. They are not intended as a guarantee of achievement. Actual results may differ significantly due to various factors in the future.
Table of Contents for Attached Materials
Overview of operating results, etc. 2
Overview of operating results for the quarter 2
Overview of financial positions for the quarter 3
Explanation regarding forward-looking statements such as consolidated forecasts 3
Quarterly Consolidated Financial Statements and Main Notes 4
Quarterly Consolidated Balance Sheet 4
Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income 6
Notes to the quarterly consolidated financial statements 8
(Notes on specific accounting treatments for the preparation of quarterly consolidated financial statements) 8
(Notes on segment information, etc.) 9
(Notes on significant changes in the amount of shareholders' equity) 11
(Notes regarding the assumption of a going concern) 11
(Notes on quarterly consolidated statement of cash flows) 11
Overview of Operating Results, etc.
Overview of operating results for the quarter
For the nine months ended September 30, 2025, the global economy continued to face instability due to persistently high geopolitical risks surrounding the situations in Ukraine and the Middle East, as well as fluctuations in crude oil and resource prices. In addition, the outlook for the global economy remained uncertain, reflecting the impact of protectionist policies such as reciprocal tariffs under the Trump administration in the United States, as well as trends in monetary policy and exchange rate fluctuations in major countries. On the other hand, the Japanese economy maintained a moderate recovery trend, supported by a rebound in personal consumption and a recovery in inbound demand. However, concerns about a slowdown in overseas economies and the impact of U.S. tariff policies have left uncertainty regarding the future outlook.
Under these circumstances, our group has established the corporate purpose of "Activate Your Life" (to solve various social issues together with stakeholders through the infinite potential of interface chemistry, thereby contributing to a richer life and a brighter future). Based on this purpose and our medium- to long-term growth vision of becoming 'the most trusted innovation company by customers worldwide,' we have formulated the three-year medium-term management plan 'INNOVATION25' (2023-2025). Currently, we are working to promote the five key strategies of the medium-term management plan: 'drastic business structure transformation,' 'focused investment,' 'productivity reform,' 'promotion of sustainable management,' and 'evolution of the big family principle.'
We will continue to transform the rapidly changing business environment into business opportunities, focus on businesses that provide increasingly essential value to society, and strive for sustainable growth.
For the nine months ended September 30, 2025, which is the final year of the three-year medium-term management plan 'INNOVATION25', net sales were 41,217 million yen (up 4.4% YoY), operating profit was 2,901 million yen (up 15.7% YoY), ordinary profit was 2,759 million yen (down 2.8% YoY), and profit attributable to owners of parent was 1,613 million yen (down 12.7% YoY).
The performance of each segment is as follows. Note that the Net sales of each segment mentioned in the text do not include internal Net sales between segments.
(Chemicals Business)
Net sales were 29,475 million yen (up 1.3% YoY), and segment profit was 2,979 million yen (up 5.9% YoY).
In our core textile chemicals business, the operation of overseas textile processing plants, which are our customers, slowed down due to the impact of the Trump tariffs. However, sales increased, particularly at our China base, driven by growth in high value-added EHD-related finished goods such as fluorine-free water repellents and process rationalization agents, as well as the acquisition of new business. In addition, sales of electronic materials-related process chemicals also increased due to a partial recovery in the semiconductor market and the acquisition of new business.
Although selling, general and administrative expenses increased due to the growth in these sales, the chemicals business recorded both higher revenue and profit.
(Cosmetics Business)
Net sales were 11,344 million yen (up 11.7% YoY), and segment profit was 1,430 million yen (up 24.0% YoY).
At our company, Demicosmetics, despite the continued uncertainty in the domestic economy due to factors such as rising prices and the challenging salon environment caused by a decrease in customer visits due to the extreme heat, we maintained steady performance through the expansion of our main hair care products and new merchandise. Among consolidated subsidiaries, although sales at DEMI KOREA CO., LTD. declined due to deteriorating market conditions, the contract business at Yamada Pharmaceutical Co., Ltd. performed well.
As a result, the cosmetics business recorded increases in both revenue and profit. (Others)
Net sales were 397 million yen (up 68.9% YoY), and segment profit was 50 million yen (compared to a segment loss of 5 million yen in the same period of the previous year).
Overview of financial positions for the quarter ( Assets)
As for the total assets at the end of the third quarter of the consolidated fiscal period, they increased by 4,123 million yen compared to the end of the previous consolidated fiscal year, reaching 66,489 million yen. The main factors for this were a decrease of 1,216 million yen in notes and accounts receivable - trade, and contract assets, while cash and deposits increased by 607 million yen, and other (net) in property, plant and equipment increased by 4,791 million yen.
( Liabilities)
As for the total liabilities at the end of the third quarter of the consolidated fiscal period, it increased by 4,265 million yen compared to the end of the previous consolidated fiscal year, reaching 30,078 million yen. The main reasons for this were an increase of 3,192 million yen in short-term borrowings and an increase of 724 million yen in long-term borrowings.
( Net assets)
As for the total net assets at the end of the third quarter of the consolidated fiscal period, it decreased by 142 million yen compared to the end of the previous consolidated fiscal year, amounting to 36,411 million yen. The main factors for this were an increase in retained earnings by 709 million yen, while foreign currency translation adjustment decreased by 665 million yen and remeasurements of defined benefit plans decreased by 472 million yen.
Explanation regarding consolidated forecasts and other forward-looking statements
No revisions have been made to the consolidated forecasts announced on July 31, 2025.
Quarterly Consolidated Financial Statements and Main Notes (1) Quarterly Consolidated Balance Sheet
(Unit: Million yen) | ||
Previous fiscal year (December 31, 2024) | For the third quarter (September 30, 2025) | |
Assets | ||
Current assets | ||
Cash and deposit | 10,726 | 11,334 |
Notes and accounts receivable - trade, and contract assets | 11,996 | 10,780 |
Merchandise and finished goods | 5,314 | 5,410 |
Work in process | 818 | 904 |
Raw materials and supplies | 4,372 | 4,494 |
Others | 1,005 | 1,144 |
Allowance for doubtful accounts | (13) | (13) |
Total current asset | 34,221 | 34,057 |
Non-current assets | ||
Property, plant, and equipment | ||
Buildings and structures, net | 12,401 | 11,733 |
Machinery, equipment and vehicles, net | 2,365 | 2,057 |
Land | 7,760 | 7,768 |
Other (net) | 1,475 | 6,266 |
Total property, plant and equipment, net | 24,002 | 27,826 |
Intangible assets | ||
Other | 510 | 827 |
Total intangible assets | 510 | 827 |
Investment Other assets | ||
Other | 3,631 | 3,778 |
Total investment and other assets | 3,631 | 3,778 |
Total non-current assets | 28,144 | 32,432 |
Total assets | 62,366 | 66,489 |
(Unit: Million yen) | ||
Previous fiscal year (December 31, 2024) | For the third quarter (September 30, 2025) | |
Liabilities | ||
Current liabilities | ||
Notes and accounts payable - trade | 6,181 | 6,038 |
Short-term borrowings | 4,300 | 7,492 |
Current portion of long-term borrowings | 1,368 | 1,368 |
Income taxes payable | 534 | 366 |
Provision for bonuses | 961 | 618 |
Provision for bonuses for directors | 15 | 14 |
Other | 3,783 | 4,440 |
Total current liabilities | 17,143 | 20,339 |
Non-current liabilities | ||
Long-term borrowings | 4,234 | 4,958 |
Liabilities for retirement benefits | 3,132 | 3,263 |
Provision for share-based payments | 210 | 224 |
Other | 1,091 | 1,292 |
Total non-current liabilities | 8,668 | 9,738 |
Total liabilities | 25,812 | 30,078 |
Net assets | ||
Shareholders' equity | ||
Share capital | 2,898 | 2,898 |
Capital surplus | 2,960 | 2,991 |
Retained earnings | 24,251 | 24,961 |
Treasury shares | (1,407) | (1,342) |
Total shareholders' equity | 28,703 | 29,509 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 719 | 798 |
Foreign currency translation adjustment | 4,119 | 3,453 |
Remeasurements of defined benefit plans | 107 | (365) |
Total accumulated other comprehensive income | 4,946 | 3,887 |
Non-controlling interests | 2,903 | 3,015 |
Total net assets | 36,553 | 36,411 |
Total liabilities and net assets | 62,366 | 66,489 |
Quarterly Consolidated Statement of Income and Quarterly Consolidated Statement of Comprehensive Income (Quarterly Consolidated Statement of Income)
(Nine months ended)
(Unit: Million yen)
For the nine months ended [previous period end date] From January 1, 2024
until September 30, 2024
For the nine months ended From January 1, 2025
until September 30, 2025
Revenue
39,476
41,217
Cost of sales
25,357
26,347
Gross profit
14,119
14,870
Selling, general and administrative expenses
11,610
11,969
Operating profit
2,508
2,901
Non-operating income
Interest income
55
80
Dividend income
24
30
Share of income of investments accounted for using the equity method
12
15
Foreign exchange gains
51
-
Other
238
132
Total non-operating income
382
259
Non-operating expenses
Interest expense
29
84
Foreign exchange losses
-
137
Commission expenses
-
141
Other
22
38
Total non-operating expenses
51
401
Ordinary profit
2,839
2,759
Extraordinary income
Gain on sale of non-current assets
2
135
Total extraordinary income
2
135
Extraordinary losses
Loss on retirement of fixed assets
4
3
Loss on sale of non-current assets
0
0
Loss on sale of investment securities
0
-
Total extraordinary losses
4
3
Net income before income taxes
2,837
2,890
Income taxes
769
1,024
Net income
2,067
1,866
Net income attributable to non-controlling interests
219
253
Profit attributable to owners of parent
1,848
1,613
(Quarterly Consolidated Statement of Comprehensive Income) (Nine months ended)
(Unit: Million yen)
For the nine months ended [previous period end date] From January 1, 2024
until September 30, 2024
For the nine months ended From January 1, 2025
until September 30, 2025
Net income
2,067
1,866
Other comprehensive income (loss), net of tax
Valuation difference on available-for-sale securities
81
79
Foreign currency translation adjustment
78
(707)
Remeasurements of defined benefit plans, net of tax
26
(471)
Other comprehensive income, net of tax
186
(1,100)
Comprehensive income
2,253
766
Comprehensive income attributable to
Quarterly comprehensive income attributable to owners of the parent
1,982
553
Quarterly comprehensive income attributable to non-controlling interests
270
213
Notes to the quarterly consolidated financial statements
(Notes on accounting treatments specific to the preparation of quarterly consolidated financial statements) (Calculation of tax expenses)
For income tax expenses, the effective tax rate after applying tax effect accounting, reasonably estimated for the fiscal year including the third quarter of the current consolidated fiscal period, is applied to pre-tax Net income to calculate the tax expense. However, if calculating tax expenses using the estimated effective tax rate results in a significantly unreasonable outcome, the statutory effective tax rate is used instead.
(Notes on segment information, etc.)
I Previous nine months ended September 30, 2024
Information on net sales and profit or loss by reportable segment
(Unit: Million yen)
Reportable segment
Other (Note)
Total
Chemicals
Cosmetics
Total
Revenue
Net sales to external customers
29,083
10,157
39,241
235
39,476
Internal net sales between segments or transfer amount
-
1
1
169
170
Total
29,083
10,158
39,242
405
39,647
Segment profit or loss (-)
2,813
1,153
3,967
(5)
3,961
(Note) The category of "Others" refers to business segments not included in the reportable segments, and includes equipment contract work.
Difference between the total amount of profit or loss of reportable segments and the amount recorded in the quarterly consolidated statement of income, and the main contents of such difference (matters related to reconciliation of differences)
(Unit: Million yen)
Profit
Amount
Total for reportable segments
3,967
Profit or loss (-) in the "Others" category
(5)
Elimination of inter-segment transactions
25
Corporate expenses (Note)
(1,477)
Operating profit in the quarterly consolidated statement of income
2,508
(Note) Company-wide expenses mainly consist of general and administrative expenses that are not attributable to any reportable segment.
Information on impairment losses of non-current assets or goodwill, etc. by reportable segment (Significant impairment losses related to non-current assets)
There are no applicable items.
(Significant changes in the amount of goodwill) There are no applicable items.
(Significant gain on bargain purchase) There are no applicable matters.
II For the nine months ended September 30, 2025
Information on net sales and profit or loss by reportable segment
(Unit: Million yen)
Reportable segment
Other (Note)
Total
Chemicals
Cosmetics
Total
Revenue
Net sales to external customers
29,475
11,344
40,819
397
41,217
Internal net sales between segments or transfer amount
1
3
4
158
163
Total
29,477
11,347
40,824
555
41,380
Segment profit or loss (-)
2,979
1,430
4,409
50
4,459
(Note) The category of "Others" refers to business segments not included in the reportable segments, and includes equipment contracting work.
Difference between the total amount of profit or loss of reportable segments and the amount recorded in the quarterly consolidated statement of income, and the main contents of such difference (matters related to reconciliation of differences)
(Unit: Million yen)
Profit
Amount
Total for reportable segments
4,409
Profit or loss (-) in the "Other" category
50
Elimination of inter-segment transactions
19
Company-wide expenses (Note)
(1,577)
Operating profit in the quarterly consolidated statement of income
2,901
(Note) Company-wide expenses mainly consist of general and administrative expenses that are not attributable to any reportable segment.
Information on Impairment losses of Non-current assets or Goodwill, etc. by reportable segment (Significant impairment losses related to non-current assets)
There are no applicable items.
(Significant changes in the amount of goodwill) There are no applicable items.
(Significant gain on bargain purchase) There are no applicable items.
(Notes in case of significant changes in the amount of shareholders' equity) There are no applicable items.
(Notes regarding the assumption of a going concern) There are no applicable items.
(Notes on quarterly consolidated statement of cash flows)
The quarterly consolidated statement of cash flows for the nine months ended September 30 has not been prepared. Depreciation for the nine months ended September 30 (including amortization of intangible assets other than goodwill) is as follows.
For the nine months ended [previous
period end date] (From January 1, 2024
For the nine months ended From January 1, 2025
until September 30, 2025
until September 30, 2024
Depreciation 1,652 million yen 1,578 million yen
